What You Should Know:
– H1, the go-to resource for healthcare professionals, clinical trial information, and life sciences research, announced the launch of its conversational AI tool GenosAI Pro.
– The conversational AI tool empowers pharmaceutical…
Continue Reading
What You Should Know:
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced today the formation of TenAces Biosciences.TenAces is a startup developing a novel approach…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup, TenAces.TenAces will utilize AI, integrating biology and machine learning algorithms, to discover molecular…
Continue Reading
What You Should Know:
– Debiopharm, a leading independent biopharmaceutical company, and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, today announced a groundbreaking partnership to propel the development of a cutting-edge cancer drug.
– This…
Continue Reading
What You Should Know:
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionise healthcare and improve the human condition using molecular science…
Continue Reading
What You Should Know: – Amgen, a global leader in biotechnology, is embarking on a groundbreaking venture: Project Freyja. – The new initiative will harness the power of an NVIDIA DGX SuperPOD, christened after…
Continue Reading
Advancements in AI-driven healthcare and pharmaceuticals are reshaping the industry, evident through recent funding and collaborations. Peptris Technologies, backed by $1 million, expands AI drug discovery to rare diseases. Cipla boosts its stake in…
Continue Reading
Indian AI drug discovery firm gets $1M to focus on rare diseasesPeptris Technologies from Bangalore, India has received $1 million in pre-seed funding in a round led by Speciale Invest.
In a statement, the AI-driven…
What You Should Know:
– Absci, a generative AI drug creation company, and PrecisionLife, a pioneer in computational biology for complex chronic diseases, have announced a powerful partnership to develop a joint portfolio of potential…
Continue Reading
What You Should Know:
Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven clinical-stage biotechnology company, today announced that the company has initiated the first-in-human study for ISM5411, a potentially first-in-class PHD inhibitor for the treatment…
Continue Reading
